An integrative analysis of DNA methylation and RNA-Seq data for human heart, kidney and liver
Open Access
- 23 December 2011
- journal article
- Published by Springer Nature in BMC Systems Biology
- Vol. 5 (S3) , S4
Abstract
Many groups, including our own, have proposed the use of DNA methylation profiles as biomarkers for various disease states. While much research has been done identifying DNA methylation signatures in cancer vs. normal etc., we still lack sufficient knowledge of the role that differential methylation plays during normal cellular differentiation and tissue specification. We also need thorough, genome level studies to determine the meaning of methylation of individual CpG dinucleotides in terms of gene expression.Keywords
This publication has 39 references indexed in Scilit:
- Postnatal loss of Dlk1 imprinting in stem cells and niche astrocytes regulates neurogenesisNature, 2011
- Chromosome-wide DNA methylation analysis predicts human tissue-specific X inactivationHuman Genetics, 2011
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationNature Biotechnology, 2010
- Mapping and quantifying mammalian transcriptomes by RNA-SeqNature Methods, 2008
- Stability and flexibility of epigenetic gene regulation in mammalian developmentNature, 2007
- Analysis of tissue-specific differentially methylated regions (TDMs) in humansGenomics, 2007
- Chromatin in pluripotent embryonic stem cells and differentiationNature Reviews Molecular Cell Biology, 2006
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- The history of cancer epigeneticsNature Reviews Cancer, 2004
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992